Co-Op America


Garden of Healing® is an online magazine and personal lifestyle guide to achieving true health through all things natural. Articles and features, recipes, and reviews; find them here. EAT SMART - LIVE WELL - LEARN ALOT!

Archive for November, 2006

Monsanto Stands Firm on Genetically-Modified Corn in Mexico

THE FUTURE OF FOOD  

Monsanto Vows to Force its Genetically-Engineered Corn Variety on Mexican Maize

Mexico City

The powerful biotech corporation Monsanto, which anti-genetic modification activists charge is corrupt, maintains that it has a positive image around the world and announces that it will continue to fight to ensure that Mexico, birthplace of maize, will open its doors to transgenic varieties of the grain.

In an interview with TierramĂ©rica in Mexico City, Eduardo PĂ©rez, director of technology development for Monsanto in northern Latin America, said that although “activism has created a mistaken perception of us,” it does not affect the company’s commercial performance.

In 2005, some 8.5 million farmers in 21 countries planted genetically modified (GM) crops over 400 million hectares. Most of the transgenic seed was produced by Monsanto.

The corporation has been accused of pressuring and bribing government officials, of going after farmers who fail to pay royalties to Monsanto for seed production, of altering scientific reports, and even of having taken part in creating agent orange, the chemical weapon that became infamous during the Vietnam War (1964-1975).

The representative from Monsanto, a company that rarely grants press interviews, denies many of those charges, but does acknowledge that there was a case of bribery. PĂ©rez announced that the firm does not plan to leave Mexico, despite the Vicente Fox government’s ban on GM maize.

 

Cost of New Biologic Therapies pegged at $1.2 Billion

THE TAKE ON PHARMACEUTICALS

Cost of New Biologic Therapies

Boston, Massachusetts

The Tufts Center for the Study of Drug Development reported in a recent study that the average cost to develop a new biotechnology product is currently $1.2 billion.

In contrast to drug development by pharmaceutical companies, development for a complex biologic therapy takes longer and costs more. To go through human testing and regulatory review, it takes 97.7 months for biotechnology products versus 90.3 months for more traditional medicines.

Tufts CSDD said the $1.2 billion estimate reflects the costs of drugs that fail in testing and the time costs associated with bringing a new biopharmaceutical to market.

“While biotech offers significant promise in treating entire categories of diseases for which no medicines previously existed, it comes at a significant cost,” said Tufts CSDD Director of Economic Analysis Joseph A. DiMasi.

Biopharmaceuticals had an overall clinical approval success rate of 30.2% vs. 21.5% for traditional pharma firm pipelines.

______________________________

The Tufts Center for the Study of Drug Development at Tufts University provides strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical development, review, and utilization. Tufts CSDD, based in Boston, conducts a wide range of in-depth analyses on pharmaceutical issues.

© 2006 Garden of Healing®. All rights reserved.

Fast Food Nation hits the Silver Screen November 17th, 2006

FILM REVIEWS

Fat Food Nation

Reviewed by Mark Isaac Thyss

9_md.jpg

Eric Schlosser’s insightful exposĂ© on the fast-food industry made the best-seller list when it was published in 2001. Now it’s coming to theaters nationwide November 17, 2006.

Fast Food Nation, the movie, shows how the fast-food industry is linked to health, social, and environmental problems—from the difficult and dangerous working conditions in meat processing plants to foodborne illness from contamination of food.

The cast includes Greg Kinnear, Avril Lavigne, Patricia Arquette, and Ethan Hawke.

__________________

For more information: http://www.foxsearchlight.com/fastfoodnation

© 2007 Garden of Healing®. All rights reserved.